Table 1

Proportion of countries (%) with available basic NCD technologies and essential medicines in primary care facilities of the public health sector, Americas Region 2019–2021

	Countries (%)
	2019	2021
All basic NCD technologies*	5	4
Measuring weight	100	97
Measuring height	100	100
Blood glucose measurement	94	94
Oral glucose tolerance test	63	69
HbA1c test	51	54
Dilated fundus examination	37	51
Foot vibration perception by tuning fork	43	51
Urine strips for glucose and ketone measurement	63	57
Blood pressure measurement	97	94
Total cholesterol measurement	77	71
Urine strips for albumin assay	60	54
Peak flow measurement spirometry	31	17
All essential NCD medicines†	17	20
Insulin	83	91
Aspirin (75/100 mg)	94	91
Metformin	94	100
Thiazide diuretics	91	89
ACE inhibitors	91	89
Angiotensin II receptor blockers	77	74
Calcium channel blockers	89	89
Beta blockers	86	91
Statins	83	86
Oral morphine	49	51
Steroid inhaler	77	77
Bronchodilator	91	89
Sulphonylurea(s)	91	97
Benzathine penicillin injection	89	89
Nicotin Replacement Therapy	23	23

Range distribution of countries (%). <25, 25–49, 50–74, 75–99, 100. WHO NCD Country Capacity Survey, 2019–2021.
*Available in 50 or more of the public healthcare facilities.
†Available in 50 or more pharmacies.
NCD, non-communicable disease.